BOULDER, Colo., Jan. 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Annual J.P. Morgan Healthcare Conference
Presenter: Ron Squarer, Chief Executive Officer, Array BioPharma
Date: Wednesday, January 11, 2017
Time: 8:30 a.m. Pacific Time
Location: Westin St. Francis Hotel, San Francisco
Webcast: http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22698
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).
CONTACT: Tricia Haugeto Array BioPharma Inc. 303-386-1193 thaugeto@arraybiopharma.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300377960.html
SOURCE Array BioPharma